Health Innovation Assessment Consultancy
Innovators and start-ups in healthcare and biotech are experts in their innovation’s scientific and technical domain but often struggle with navigating the complex world of the healthcare industry.
If you want to objectively show the advantages and competitiveness of your innovation to potential investors, future users, (reimbursement) payers or even the media, you can greatly benefit from Panaxea’s Health Innovation Assessment solution.
By making use of robust methods to collect and analyse data, Health Innovation Assessment (HIA) aims to comprehensively assess the added value of (bio-)medical and healthcare innovations. HIA takes into account true multi-stakeholder perspectives on value assessment and the realm of marketplace decision making.
Where Medical Technology Assessment (MTA) or Health Technology Assessment (HTA) address value assessment of innovations for primarily scientific interest, HIA supports innovators and their stakeholders to make better-informed decisions about the value of innovations. HIA makes use of health economics, health services and policy research, market access analysis, and implementation science.
If you are interested in HIA, we would be happy to advise you starting with a 1,5h consultation. First, you are invited to present your innovation and your information needs. Based on the input, two of our experts will provide you with solid advice on how to move forward and design the best strategy for you to succeed with your product or service.
You can expect the highest level of decision-making support from our internationally renowned experts including Hubertus Vrijhoef, PhD and Nick Guldemond, PhD DSc.